A major breakthrough has occurred in the fight against canine cancer, thanks to Elias Animal Health, a Lenexa-based biotechnology firm. The company has recently received full regulatory approval from the U.S. Department of Agriculture (USDA) for a revolutionary gene therapy treatment designed to target bone cancer in dogs, a condition that has traditionally been difficult to treat with existing therapies.